TY - JOUR T1 - Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19) JO - Actas Dermo-Sifiliográficas T2 - AU - Carrascosa,J.M. AU - Morillas,V. AU - Bielsa,I. AU - Munera-Campos,M. SN - 15782190 M3 - 10.1016/j.adengl.2020.10.001 DO - 10.1016/j.adengl.2020.10.001 UR - https://www.actasdermo.org/en-cutaneous-manifestations-in-context-sars-cov-2-articulo-S1578219020302754 AB - The coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had enormous health, economic, and social consequences. The clinical spectrum of cutaneous manifestations observed in patients with COVID-19 is both heterogeneous and complex. To date, reports have identified 5 main categories: acral lesions, vesicular rashes, urticarial rashes, maculopapular rashes, and livedoid and necrotic lesions. However, these will probably be modified as new information comes to light. Cutaneous manifestations associated with COVID-19 probably reflect the activation of pathogenic pathways by the virus or a response to inflammatory processes, vascular or systemic complications, or even treatments. Familiarity with the cutaneous manifestations of COVID-19 may enable early diagnosis or help guide prognosis. ER -